Ats Corporation · TSX:ATS

Ats — Q1 FY2025 Earnings Presentation

27 slides from Ats's earnings presentation, August 2024

  1. Slide 1: Investor Presentation August 2024

    Investor Presentation August 2024

  2. Slide 2: Disclaimer

    Disclaimer Note to Reader: This informational meeting regarding ATS Corporation is for you to familiarize yourself with the Company. We are not making any offers of securities at this time, and cannot accept orders for any securities at this time. Accordingly, this presentation shall not constitute

  3. Slide 3: Disclaimer

    Disclaimer Non-IFRS and Other Financial Measures: Throughout this presentation management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company. The terms “EBITDA”, “organic revenue”, “adjusted EBITDA”, "EBIT for ret

  4. Slide 4: A Decentralized Automation & Technology Leader

    A Decentralized Automation & Technology Leader Strategic Provider of End-to-End Automation Solutions Strong Execution Across Our Business Driving Performance and Innovation Delivering Improvement and Growth Positioned for Continued Strong Performance 4

  5. Slide 5: ATS at a Glance

    Strategic Provider of End-to-End Automation Solutions ATS at a Glance STRONG FINANCIAL PERFORMANCE(1), (2), (3) SIGNIFICANT SCALE & CAPABILITIES C$3.0B Revenues (TTM) 65+ 85+ 20+ 7,000+ Facilities Offices Countries Employees 8.6% 19.3% 5-yr Avg. Organic 5-yr Revenue CAGR Revenue Growth C$457mm 15.4%

  6. Slide 6: Focused on Large Attractive End Markets

    Strategic Provider of End-to-End Automation Solutions Focused on Large Attractive End Markets Life Sciences Transportation Energy Food & Beverage Consumer Products • Medical devices • EV / Hybrid • Nuclear • Produce Processing • Warehouse Automation • Pharmaceuticals • Automotive • Clean energy • So

  7. Slide 7: Transforming, Streamlining, and Optimizing Customer Operations

    Strategic Provider of End-to-End Automation Solutions Transforming, Streamlining, and Optimizing Customer Operations 1. Custom Integration Customer Outputs • Discovery, Analysis, Concept Development • Design / Build Increased Efficiency • IT & MES Integration Improved Quality 2. Products & Equipment

  8. Slide 8: ATS Business Model (ABM) is Our DNA

    Strategic Provider of End-to-End Automation Solutions ATS Business Model (ABM) is Our DNA 8

  9. Slide 9: ABM Drives Improvement

    Strategic Provider of End-to-End Automation Solutions ABM Drives Improvement (1) EBIT Margin is also referred to as operating margin, which is a supplementary financial measure, please refer to "Non-IFRS Measures and Other IFRS Measures" disclaimer. 9

  10. Slide 10: Our Value Drivers are Directly Tied to ROIC

    Strategic Provider of End-to-End Automation Solutions Our Value Drivers are Directly Tied to ROIC Focus on Financial Value Drivers Has Driven Improvement in ROIC 13.5% 13.3% 13.3% 13.0% 12.7% 12.4% 12.2% F2018 F2019 F2020 F2021 F2022 F2023 F2024 ROIC (TTM) (1) EBIT Margin is also referred to as oper

  11. Slide 11: Portfolio Growth and Transformation

    Strong Execution Across Our Business Portfolio Growth and Transformation COVID-19 Name change & response, rebrand Acquire KMW, Acquire IPCOS, ZI- divest ATW, Acquire Paxiom Symphoni and Comecer acquire CFT Argus, and Triad and Heidolph2 TTM1 13% F2019 F2023 F2025 F2021 14% 10% 12% 44% 47% 4% F2022 F

  12. Slide 12: Purposeful Shift in Business Mix

    Strong Execution Across Our Business Purposeful Shift in Business Mix Consistent growth while intentionally Services rendered shifting the nature of revenue $1.1B $591.1M FY 2018 Revenue 27% FY 2013 Revenue $3.0B 47% 38% FY 2024 Revenue 10% 52% 26% (1) Sale of goods Revenue by Type Custom Integratio

  13. Slide 13: Targeting Value Creation in Attractive Markets

    Driving Performance and Innovation Strategic Approach to M&A will Remain a Key Growth Driver Recent Other What We Look For Acquisitions Acquisitions Heidolph Successfully Executing Our Playbook Life sciences equipment manufacturer • Growth oriented Announced: August 20242 Targeting Value Creation in

  14. Slide 14: Key Elements of Our Strategy

    Driving Performance and Innovation Key Elements of Our Strategy Innovation Digital Growth Portfolio Management Margin Improvement Ongoing focus to drive Expanding how data and Target markets with high Using different levers strong returns and insights are collected and barriers to entry, including w

  15. Slide 15: Continuous Focus on Margin Improvement

    Delivering Improvement and Growth Continuous Focus on Margin Improvement Primary Levers Supply Chain Standardization Operating Leverage Shift in Business Mix (i.e., growth in services) ABM Initiatives Strengthening Pillars Scale & Flexibility Through Global Employee Base Total Revenue(1), (2) Adj. E

  16. Slide 16: Leverage Managed in the Context of Significant M&A

    Positioned for Continued Strong Performance Leverage Managed in the Context of Significant M&A Net Debt to Adj EBITDA(1,2) Trend Leverage Framework 3.5 • Willing to temporarily exceed for the right target 3.0 • Target must meet ATS’ strict and consistent acquisition Target criteria 2.5 Range • Demon

  17. Slide 17: Capital Allocation Priorities – Powering the Flywheel

    Positioned for Continued Strong Performance Capital Allocation Priorities – Powering the Flywheel Generate Capital Access External Capital Cash flow from operations • Credit Facility • Growth • Debt Markets • Margin Expansion • Equity Markets • Working Capital Deploy Capital • Internal Investment •

  18. Slide 18: Long-Term Targets Aligned to Value Creation

    Positioned for Continued Strong Performance Long-Term Targets Aligned to Value Creation 1 2 3 Growth Margin Expansion FCF(1) Generation Above Market Organic + +15% Adjusted EBIT 100% of Net Income Acquisitions Margin1 (multi-year target) (1) Adjusted EBIT margin is a Non-IFRS ratio and free cash flo

  19. Slide 19: Key Takeaways

    Key Takeaways 1 2 3 4 5 Strategic Provider of Strong Driving Performance Delivering Improvement Positioned for Continued Automation Solutions Execution and Innovation and Growth Strong Performance Entrenched position with Throughout our Proven strategy with Executing across our Long runway to grow h

  20. Slide 20: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix Reconciliation of Non-IFRS Measures to IFRS Measures 20

  21. Slide 21: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted EBITDA and EBITDA to the most directly comparable IFRS measure (net income) (in millions of dollars): Order Backlog Continuity (in millions of dollars) (C$ mm) Q1 Q1 Measure (C$ mm)1 Q1 F2019 F2020

  22. Slide 22: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles working capital to the most directly comparable IFRS measures (in millions of dollars): Measure (C$ mm) Q1 F2019 F2020 F2021 F2022 F2023 F2024 F2025 Accounts receivable 217.2 291.1 285.9 348.6 399.7 471.3 5

  23. Slide 23: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles organic revenue to the most directly comparable IFRS measure (revenue) (in millions of dollars): (C$ mm) F2019 F2020 F2021 F2022 F2023 F2024 Organic revenue 1,230.5 1,327.1 1,388.0 1,721.9 2,382.1 2,852.6 R

  24. Slide 24: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles net debt to the most directly comparable IFRS The following table reconciles free cash flow to the most directly measure (in millions of dollars): comparable IFRS measure (in millions of dollars): (C$ mm) M

  25. Slide 25: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles the previously reported non-IFRS financial measures to reflect the exclusion of the stock-based compensation revaluation expenses: (C$ mm) Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 F2022 F2023 F2023 F2024 F2024 F2024 F2024 F

  26. Slide 26: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures Earnings from operations for ROIC purposes to the most directly comparable IFRS measure (net income) (in millions of dollars): (C$ mm) F2018 F2019 F2020 F2021 F2022 F2023 F2024 Earnings from operations for ROIC 117.3 138.1 155.9 167.4 25

  27. Slide 27: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures

    Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles invested capital to the most directly comparable IFRS measure (in millions of dollars): (C$ mm) Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 F17 F18 F18 F18 F18 F19

ATS — Q1 FY2025 Earnings Presentation on 6ix